{"id":"https://openalex.org/W2476016237","doi":null,"title":"CONSUMPTION ANALYSIS OF METFORMIN, SULFONYLUREAS, AND OTHER ANTIDIABETICS DRUGS IN MOROCCO (1991-2005)","display_name":"CONSUMPTION ANALYSIS OF METFORMIN, SULFONYLUREAS, AND OTHER ANTIDIABETICS DRUGS IN MOROCCO (1991-2005)","publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W2476016237","mag":"2476016237"},"language":"en","primary_location":{"id":"mag:2476016237","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10645","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10645","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026564478","display_name":"Mohammed Abdessadek","orcid":"https://orcid.org/0000-0002-9297-2493","observed_orcids":["https://orcid.org/0000-0002-9297-2493"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Abdessadek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9297-2493","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ahmed El Attari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed El Attari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001144729","display_name":"Martin Diarra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Diarra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112084612","display_name":"Rabia Magoul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rabia Magoul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027141583","display_name":"Seloua El Ouezzani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seloua El Ouezzani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006851287","display_name":"Youssef Khabbal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youssef Khabbal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048290044","display_name":"F. Ajdi","orcid":"https://orcid.org/0000-0001-7456-7331","observed_orcids":["https://orcid.org/0000-0001-7456-7331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Ajdi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7456-7331","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"8","first_page":"85","last_page":"88"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8840000033378601},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.7360000014305115},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9890000224113464},{"id":"https://openalex.org/keywords/biguanides","display_name":"biguanides","score":0.9760000109672546},{"id":"https://openalex.org/keywords/glinides","display_name":"glinides","score":0.8840000033378601},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9860000014305115},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.800000011920929},{"id":"https://openalex.org/keywords/morocco","display_name":"Morocco","score":0.5609999895095825},{"id":"https://openalex.org/keywords/ukpds","display_name":"UKPDS","score":0.9300000071525574},{"id":"https://openalex.org/keywords/sales-data","display_name":"sales data","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8971776962280273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8340625762939453},{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.6938243508338928},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5599237084388733},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5374406576156616},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.515572726726532},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.44439780712127686},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.3935225009918213},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.39183446764945984},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36254969239234924},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24657514691352844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2293020784854889},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.21297279000282288},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2476016237","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10645","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null}],"best_oa_location":{"id":"mag:2476016237","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10645","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1541247563","https://openalex.org/W1964423574","https://openalex.org/W1967813980","https://openalex.org/W1974901485","https://openalex.org/W1975588287","https://openalex.org/W2028212562","https://openalex.org/W2037458784","https://openalex.org/W2053658037","https://openalex.org/W2064899607","https://openalex.org/W2074427854","https://openalex.org/W2148382332","https://openalex.org/W2158822657","https://openalex.org/W2164733897","https://openalex.org/W2166295381","https://openalex.org/W2337454357"],"related_works":["https://openalex.org/W2054054907","https://openalex.org/W2582026922","https://openalex.org/W2063626413","https://openalex.org/W4408409993","https://openalex.org/W2419231324","https://openalex.org/W2385618599","https://openalex.org/W2354831569","https://openalex.org/W2358201775","https://openalex.org/W2353239342","https://openalex.org/W2369349716"],"abstract_inverted_index":{"Objective":[0],":":[1],"Type":[4],"2":[5],"Diabetes":[6],"is":[7,168],"one":[8],"of":[9,40,50,56,70,152,165,172,176,183],"the":[10,31,38,48,54,57,68,71,104,107,115,137,150,159,163,170,181,198],"chronic":[11],"diseases":[12],"with":[13],"a":[14,19],"high":[15],"prevalence":[16],"and":[17,47,120,192,200],"consequently":[18],"substantial":[20],"socio-economic":[21],"burden":[22],"in":[23,35,128,149,156,162],"Arab":[24],"countries.":[25],"In":[26,102],"this":[27],"paper,":[28],"we":[29],"evaluated":[30],"antidiabetic":[32,92],"drugs":[33,93,167],"consumption":[34,55,77,94,126,151],"Morocco":[36],"during":[37],"period":[39],"1991":[41],"to":[42,81,98],"2005,":[43],"drug":[44],"classes":[45],"used":[46,64],"effect":[49],"major":[51],"studies":[52,196],"on":[53],"biguanides.":[58],"Methods:":[61],"We":[63],"sales":[65],"data":[66],"from":[67,96],"subsidiaries":[69],"Intercontinental":[72],"Marketing":[73],"Service":[74],"Health.":[75],"The":[76,124],"volume":[78,129],"was":[79,130,189],"converted":[80],"Defined":[82],"Daily":[83],"Dose":[84],"(DDD).":[85],"Results:":[88],"During":[90],"1991-2005":[91,155],"increased":[95,173,177],"1.37":[97],"4.22":[99],"DDD/1000":[100,111,118],"inhabitants/day.":[101],"2005":[103],"sulfonylureas":[105,133],"were":[106],"most":[108],"consumed":[109],"2.96":[110],"inhabitants/day)":[112,119],"followed":[113,135],"by":[114,132,136,194],"Biguanides":[116],"(1.06":[117],"glinides":[121],"0.1":[122],"DDD/1000inhabitants/day.":[123],"largest":[125],"share":[127],"held":[131],"72.22%,":[134],"biguanides":[138],"22.22%.":[139],"Conclusion:":[142],"This":[144],"study":[145],"documents":[146],"progressive":[147],"changes":[148],"antidiabetic\u2019s":[153,166],"between":[154],"Morocco.":[157],"However,":[158],"significant":[160],"increase":[161],"utilization":[164],"not":[169],"result":[171],"adherence":[174],"but":[175],"patient":[178],"number,":[179],"since":[180],"use":[182],"metformin":[184],"as":[185,197],"first":[186],"line":[187],"therapy":[188],"still":[190],"suboptimal":[191],"influenced":[193],"different":[195],"Campbell":[199],"UKPDS":[201],"study.":[202]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}